2021

September 20, 2021

Griffin Institutional Access® Real Estate Fund Announces Third Quarter 2021 Distribution

EL SEGUNDO, California (September 20, 2021) – Griffin Capital Company, LLC announced today on behalf of Griffin Institutional Access Real Estate Fund (the “Fund”) a third quarter distribution of $0.363 per Class A share (NASDAQ: GIREX), $0.347 per Class C share (NASDAQ: GCREX), $0.368 per Class I share (NASDAQ: GRIFX), $0.359 per Class L share (NASDAQ: GLREX), and $0.354 per Class M share (NASDAQ: GMREX), or a 5.22% annualized distribution rate. The distribution will be paid on September 24, 2021, to shareholders of record as of September 16, 2021, with an ex-dividend date of September 17, 2021.
August 03, 2021

Griffin Institutional Access Real Estate Fund Extends Positive Performance

Griffin Capital Company, LLC announced today that in July 2021 Griffin Institutional Access Real Estate Fund (the “Fund”) generated its highest monthly return since inception.
July 06, 2021

Griffin Institutional Access Real Estate Fund Generated Highest Quarterly Return Since Inception

Griffin Capital Company, LLC announced today that in the second quarter of 2021, Griffin Institutional Access Real Estate Fund (the “Fund”) generated its highest quarterly return since inception.
June 28, 2021

Griffin Institutional Access® Real Estate Fund Announces Second Quarter 2021 Distribution

Griffin Capital Company, LLC announced today on behalf of Griffin Institutional Access Real Estate Fund (the “Fund” – NASDAQ: GIREX, GCREX, GRIFX, GLREX, GMREX) a second quarter distribution of $0.352 per Class A share (NASDAQ: GIREX), $0.337 per Class C share (NASDAQ: GCREX), $0.357 per Class I share (NASDAQ: GRIFX), $0.349 per Class L share (NASDAQ: GLREX), and $0.344 per Class M share (NASDAQ: GMREX), or a 5.22% annualized distribution rate*. The distribution was paid on June 25, 2021, to shareholders of record as of June 17, 2021, with an ex-dividend date of June 18, 2021.
May 04, 2021

Griffin Institutional Access Real Estate Fund Generated Highest Monthly Return Since Inception

Griffin Capital Company, LLC announced today that Griffin Institutional Access Real Estate Fund (the “Fund”) generated its highest monthly return since inception in April 2021.
April 15, 2021

Griffin Institutional Access Real Estate Fund Announces Continued Commitment to High Conviction Investment Themes

Griffin Capital Company, LLC announced today the release of Griffin Institutional Access Real Estate Fund’s (the “Fund”) holdings summary as of April 1, 2021. With net assets of $3.89 billion, the Fund’s holdings represent a continued commitment to the portfolio management team’s 2021 high conviction themes— industrial, multifamily, and specialty properties, together with private real estate debt.
April 05, 2021

Griffin Institutional Access Real Estate Fund Generates Second Highest Quarterly Return Since Inception

Griffin Capital Company, LLC announced today that Griffin Institutional Access Real Estate Fund (the “Fund”) generated its second highest quarterly return since inception.
March 25, 2021

Dr. Randy Anderson Speaks to the Benefits of Alternative Investments at the Forbes Shook Virtual Top Advisor Summit

Griffin Capital Company, LLC announced Dr. Randy Anderson’s participation in the Forbes Shook Virtual Top Advisor Summit.
March 19, 2021

Griffin Institutional Access® Real Estate Fund Announces First Quarter Distribution

EL SEGUNDO, California (March 19, 2021) – Griffin Capital Company, LLC announced today on behalf of Griffin Institutional Access Real Estate Fund (NASDAQ: GIREX, GCREX, GRIFX, GLREX, GMREX) the first quarter distribution of $0.339 for Class A, $0.325 for Class C, $0.344 for Class I, $0.336 for Class L, and $0.332 for Class M, or
March 16, 2021

GRIFFIN INSTITUTIONAL ACCESS® REAL ESTATE FUND ANNOUNCES CONTINUED INVESTMENT IN THE LIFE SCIENCES SECTOR

Griffin Capital Company, LLC announced today that Griffin Institutional Access Real Estate Fund (the “Fund”) has made an additional investment into the life sciences sector in the form of a follow-on investment into one of the Fund’s existing life sciences private fund holdings.